This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:diseases:psoriasis [08.30.2012] – paulalbert | home:diseases:psoriasis [08.30.2012] – paulalbert | ||
---|---|---|---|
Line 7: | Line 7: | ||
The Marshall Protocol treats psoriasis by reactivating the innate immune response. In the course of treatment, patients' | The Marshall Protocol treats psoriasis by reactivating the innate immune response. In the course of treatment, patients' | ||
- | |||
Line 23: | Line 22: | ||
* **cell wall deficient bacteria** – In a 2009 study, Wang investigated the carriage rate of cell wall deficient bacteria in the tonsil or pharynx of psoriasis patients. Cell wall deficient bacteria, a term often used interchangeably with l-form, were isolated from 74.2% of psoriasis patients, 23.5% of chronic tonsillitis patients and only 6.3% of controls.(({{pubmed> | * **cell wall deficient bacteria** – In a 2009 study, Wang investigated the carriage rate of cell wall deficient bacteria in the tonsil or pharynx of psoriasis patients. Cell wall deficient bacteria, a term often used interchangeably with l-form, were isolated from 74.2% of psoriasis patients, 23.5% of chronic tonsillitis patients and only 6.3% of controls.(({{pubmed> | ||
- | * **differences in microbiota between psoriasis and normal skin** – A 2008 study of psoriatic skin not only found 84 novel species never before known to persist in skin, but also double the proportion of microbes from the // | + | * **differences in microbiota between psoriasis and normal skin** – A 2008 study of psoriatic skin not only found 84 novel species never before known to persist in skin, but also double the proportion of microbes from the // |
- | + | * **bacterial DNA in blood of psoriatic patients** – Peripheral blood samples from 20 patients with psoriasis and from 16 control subjects were studied for the presence of bacteria by PCR using universal 16S ribosomal DNA primers | |
- | + | ||
- | + | ||
- | Superantigens(({{pubmed> | + | |
- | + | ||
- | microorganisms | + | |
- | + | ||
- | (({{pubmed> | + | |